Title |
Dynamin inhibitors induce caspase-mediated apoptosis following cytokinesis failure in human cancer cells and this is blocked by Bcl-2 overexpression
|
---|---|
Published in |
Molecular Cancer, June 2011
|
DOI | 10.1186/1476-4598-10-78 |
Pubmed ID | |
Authors |
Sanket Joshi, Antony W Braithwaite, Phillip J Robinson, Megan Chircop |
Abstract |
The aim of both classical (e.g. taxol) and targeted anti-mitotic agents (e.g. Aurora kinase inhibitors) is to disrupt the mitotic spindle. Such compounds are currently used in the clinic and/or are being tested in clinical trials for cancer treatment. We recently reported a new class of targeted anti-mitotic compounds that do not disrupt the mitotic spindle, but exclusively block completion of cytokinesis. This new class includes MiTMAB and OcTMAB (MiTMABs), which are potent inhibitors of the endocytic protein, dynamin. Like other anti-mitotics, MiTMABs are highly cytotoxic and possess anti-proliferative properties, which appear to be selective for cancer cells. The cellular response following cytokinesis failure and the mechanistic pathway involved is unknown. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 4% |
United States | 1 | 4% |
Ireland | 1 | 4% |
Unknown | 22 | 88% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 7 | 28% |
Student > Master | 5 | 20% |
Researcher | 4 | 16% |
Student > Bachelor | 2 | 8% |
Other | 2 | 8% |
Other | 3 | 12% |
Unknown | 2 | 8% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 13 | 52% |
Medicine and Dentistry | 4 | 16% |
Biochemistry, Genetics and Molecular Biology | 2 | 8% |
Chemistry | 2 | 8% |
Immunology and Microbiology | 1 | 4% |
Other | 1 | 4% |
Unknown | 2 | 8% |